J. Virol., Oct 1996, 6733-6740, Vol 70, No. 10
Copyright © 1996, American Society for Microbiology

Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro

CA Smith, LS Woodruff, GR Kitchingman and CM Rooney
Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101, USA.

Adenovirus infections cause significant morbidity and mortality in immunocompromised patients, yet little is known about the immune response to adenovirus infections. We established a system for the generation of a cytotoxic immune response to adenovirus in vitro. Cytotoxic T cells (CTLs) were derived from normal donors by using peripheral blood dendritic cells as antigen-presenting cells. The CTLs were found to contain a mixture of effector cells that recognized virus peptides in the context of both class I and class II antigens. Endogenous viral gene expression was not required to sensitize cells to lysis by adenovirus-specific CTLs. CTLs raised against subgroup C adenovirus type 5 can lyse cells infected with subgroup B adenovirus type 11, indicating that viruses of different subgroups have epitopes in common. This system holds promise for defining the human immune response to adenovirus, including characterization of the viral protein(s) against which the response is generated, and the identity of the effector cells. Such studies are in progress.

This article has been cited by other articles:

• Leen, A. M., Christin, A., Khalil, M., Weiss, H., Gee, A. P., Brenner, M. K., Heslop, H. E., Rooney, C. M., Bollard, C. M. (2008). Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy. J. Virol. 82: 546-554 [Abstract] [Full Text]  
• Onion, D., Crompton, L. J., Milligan, D. W., Moss, P. A. H., Lee, S. P., Mautner, V. (2007). The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. J. Gen. Virol. 88: 2417-2425 [Abstract] [Full Text]  
• Heemskerk, B., van Vreeswijk, T., Veltrop-Duits, L. A., Sombroek, C. C., Franken, K., Verhoosel, R. M., Hiemstra, P. S., van Leeuwen, D., Ressing, M. E., Toes, R. E. M., van Tol, M. J. D., Schilham, M. W. (2006). Adenovirus-Specific CD4+ T Cell Clones Recognizing Endogenous Antigen Inhibit Viral Replication In Vitro through Cognate Interaction. J. Immunol. 177: 8851-8859 [Abstract] [Full Text]  
• Thiele, A. T., Sumpter, T. L., Walker, J. A., Xu, Q., Chang, C.-H., Bacallao, R. L., Kher, R., Wilkes, D. S. (2006). Pulmonary Immunity to Viral Infection: Adenovirus Infection of Lung Dendritic Cells Renders T Cells Nonresponsive to Interleukin-2. J. Virol. 80: 1826-1836 [Abstract] [Full Text]  
• LEEN, A. M., MYERS, G. D., BOLLARD, C. M., HULS, M. H., SILI, U., GEE, A. P., HESLOP, H. E., ROONEY, C. M. (2005). T-Cell Immunotherapy for Adenoviral Infections of Stem-Cell Transplant Recipients. Ann. N. Y. Acad. Sci. 1062: 104-115 [Abstract] [Full Text]  
• Perreau, M., Kremer, E. J. (2005). Frequency, Proliferation, and Activation of Human Memory T Cells Induced by a Nonhuman Adenovirus. J. Virol. 79: 14595-14605 [Abstract] [Full Text]  
• Lenaerts, L., Verbeken, E., De Clercq, E., Naesens, L. (2005). Mouse Adenovirus Type 1 Infection in SCID Mice: an Experimental Model for Antiviral Therapy of Systemic Adenovirus Infections. Antimicrob. Agents Chemother. 49: 4689-4699 [Abstract] [Full Text]  
• Leen, A. M., Sili, U., Savoldo, B., Jewell, A. M., Piedra, P. A., Brenner, M. K., Rooney, C. M. (2004). Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 103: 1011-1019 [Abstract] [Full Text]  
• Heemskerk, B., Veltrop-Duits, L. A., van Vreeswijk, T., ten Dam, M. M., Heidt, S., Toes, R. E. M., van Tol, M. J. D., Schilham, M. W. (2003). Extensive Cross-Reactivity of CD4+ Adenovirus-Specific T Cells: Implications for Immunotherapy and Gene Therapy. J. Virol. 77: 6562-6566 [Abstract] [Full Text]  
• Gottschalk, S., Edwards, O. L., Sili, U., Huls, M. H., Goltsova, T., Davis, A. R., Heslop, H. E., Rooney, C. M. (2003). Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies. Blood 101: 1905-1912 [Abstract] [Full Text]  
• Roth, M. D., Cheng, Q., Harui, A., Basak, S. K., Mitani, K., Low, T. A., Kiertscher, S. M. (2002). Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses. J. Immunol. 169: 4651-4656 [Abstract] [Full Text]  
• Chakrabarti, S., Mautner, V., Osman, H., Collingham, K. E., Fegan, C. D., Klapper, P. E., Moss, P. A. H., Milligan, D. W. (2002). Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100: 1619-1627 [Abstract] [Full Text]  
• YOUNG, L S, MAUTNER, V (2001). The promise and potential hazards of adenovirus gene therapy. Gut 48: 733-736 [Full Text]  
• Morelli, A. E., Larregina, A. T., Ganster, R. W., Zahorchak, A. F., Plowey, J. M., Takayama, T., Logar, A. J., Robbins, P. D., Falo, L. D., Thomson, A. W. (2000). Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-kappa B-Dependent Pathway. J. Virol. 74: 9617-9628 [Abstract] [Full Text]  
• Chang, C.-C. J., Wright, A., Punnonen, J. (2000). Monocyte-Derived CD1a+ and CD1a- Dendritic Cell Subsets Differ in Their Cytokine Production Profiles, Susceptibilities to Transfection, and Capacities to Direct Th Cell Differentiation. J. Immunol. 165: 3584-3591 [Abstract] [Full Text]  
• Molinier-Frenkel, V., Gahery-Segard, H., Mehtali, M., Le Boulaire, C., Ribault, S., Boulanger, P., Tursz, T., Guillet, J.-G., Farace, F. (2000). Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes. J. Virol. 74: 7678-7682 [Abstract] [Full Text]  
• Ranieri, E., Herr, W., Gambotto, A., Olson, W., Rowe, D., Robbins, P. D., Kierstead, L. S., Watkins, S. C., Gesualdo, L., Storkus, W. J. (1999). Dendritic Cells Transduced with an Adenovirus Vector Encoding Epstein-Barr Virus Latent Membrane Protein 2B: a New Modality for Vaccination. J. Virol. 73: 10416-10425 [Abstract] [Full Text]  
• Nishioka, Y., Hirao, M., Robbins, P. D., Lotze, M. T., Tahara, H. (1999). Induction of Systemic and Therapeutic Antitumor Immunity Using Intratumoral Injection of Dendritic Cells Genetically Modified to Express Interleukin 12. Cancer Res. 59: 4035-4041 [Abstract] [Full Text]  
• Vollmer, C. M. Jr., Eilber, F. C., Butterfield, L. H., Ribas, A., Dissette, V. B., Koh, A., Montejo, L. D., Lee, M. C., Andrews, K. J., McBride, W. H., Glaspy, J. A., Economou, J. S. (1999). {{alpha}}-Fetoprotein-specific Genetic Immunotherapy for Hepatocellular Carcinoma. Cancer Res. 59: 3064-3067 [Abstract] [Full Text]  
• Lusky, M., Christ, M., Rittner, K., Dieterle, A., Dreyer, D., Mourot, B., Schultz, H., Stoeckel, F., Pavirani, A., Mehtali, M. (1998). In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted. J. Virol. 72: 2022-2032 [Abstract] [Full Text]